ENGLEWOOD, CO / ACCESSWIRE / January 31, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…
STRATHROY, Ontario, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;…
-- Phase 3 Sabizabulin COVID-19 Clinical Study for Treatment of Hospitalized Moderate to Severe COVID-19 Patients at High Risk for…
NEW YORK and SYDNEY, Australia, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the…
EV Insurance Company, Inc. DBA OZOP Plus Preparing for Launch Florida, NY, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ozop Energy…
Preclinical results demonstrate safe and efficient immune response with vaccine development showing promise of neutralizing activity for a range of…
Franciscan Health Franciscan Health Indianapolis INDIANAPOLIS, Indiana, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Franciscan Health joins an elite group of…
BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,…
ImmixBio Initiates IMX-110 GMP Manufacturing Scale-Up, Potentially Accelerating Clinical Trial Data Immix Biopharma, Inc. (NASDAQ:IMMX) Manufactured IMX-110 to be utilized…
New CEO foresees revenue growth from commercial medical product launches in $4 billion addressable marketNEW YORK, Jan. 31, 2022 (GLOBE…